Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...

A new study has confirmed genital herpes is the most common sexually transmitted infection (STI) in the world that does not have a cure and is lifelong. The burden on global health is immense.

For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...

More than one in five people aged between 15 and 49 globally or 846 million people live with a genital herpes infection, according to an estimate by the World Health Organization (WHO). Every second, ...

Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released today. At least 1 person ...

There are two types of herpes simplex virus (HSV). HSV-1 most commonly causes orolabial infection, while HSV-2 most commonly causes genital infection. HSV infection is very common, with 45%-98% of the ...

People with a genital infection of the herpes simplex virus type 1 (HSV-1), which usually causes cold sores, frequently shed the virus in the first months after infection, raising the risk that they ...

Infection with the virus that’s the main cause of cold sores may double a person’s risk of developing dementia, according to a new study. Adding to growing evidence of a link between the two, further ...

The incidence of neonatal herpes simplex virus (HSV) infections in the UK and Ireland increased dramatically over 15 years, and outcomes remained poor, with mortality and long-term neurologic ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc. (NASDAQ ...